e-learning
resources
Amsterdam 2011
Wednesday, 28.09.2011
Role of the biomarkers in airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Discrimination of protein and peptide composition of exhaled breath condensate in patients with pulmonary disease by mass spectrometry
A. Ryabokon, V. Kurova, E. Anaev, A. Kononikhin, K. Fedorchenko, E. Nikolaev, S. Varfolomeev (Moscow, Russian Federation)
Source:
Annual Congress 2011 - Role of the biomarkers in airway diseases
Session:
Role of the biomarkers in airway diseases
Session type:
Poster Discussion
Number:
4792
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Ryabokon, V. Kurova, E. Anaev, A. Kononikhin, K. Fedorchenko, E. Nikolaev, S. Varfolomeev (Moscow, Russian Federation). Discrimination of protein and peptide composition of exhaled breath condensate in patients with pulmonary disease by mass spectrometry. Eur Respir J 2011; 38: Suppl. 55, 4792
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
The application of mass spectrometry to the analysis and characterization of protein and peptide composition in exhaled breath condensate of pneumo-oncological diseased persons
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011
SELDI-TOF MS for proteomic analysis of exhaled breath condensate from patients with pulmonary emphysema
Source: Annual Congress 2009 - COPD: basic science and clinical studies
Year: 2009
Human skin keratins are the major proteins in exhaled breath condensate
Source: Eur Respir J 2008; 31: 380-384
Year: 2008
Determination of volatile organic compounds in exhaled breath of patients with chronic obstructive pulmonary disease by gas chromatography mass spectrometry
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010
Processing optimization of exhaled breath condensate previous to the analysis by mass spectrometry
Source: Annual Congress 2012 - Mechanics, muscles and movement: aspects of airway mechanics, repiratory muscle assessment and field exercise tests
Year: 2012
Differential ion mobility spectrometry for detection of metabolites in exhaled breath in airway diseases
Source: Annual Congress 2009 - Airway inflammation and asthma control
Year: 2009
Phenotyping of patients with COPD from exhaled air by ion mobility spectrometry
Source: Annual Congress 2012 - COPD monitoring in stable disease and during exacerbation
Year: 2012
Detection of infectious agents in the airways by ion mobility spectrometry in exhaled breath
Source: Annual Congress 2010 - Mechanisms of respiratory infections
Year: 2010
Exhaled breath analysis by ion mobility spectrometry in children with asthma and cystic fibrosis
Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research
Year: 2018
Differentialion mobility spectrometry (DMS) for discrimination of local gut infection in exhaled breath
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010
Clusters of biomarkers in exhaled breath detected by differential ion mobility spectrometry (DMS)
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011
How to measure exhaled breath MDA in normal subjects: assessment of two ionisation modes used by LC-MS/MS.
Source: Annual Congress 2008 - Investigation, inspiration, ventilation, dedication: the essence of physiological measurement
Year: 2008
Relationship of inflamamatory markers in blood and exhaled breath condensate in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 283s
Year: 2006
Analysis of exhaled breath condensate proteom and BAL Proteom by matrix assisted laser desorption/ioniosation – time of flight (MALDI-TOF) from patients with acute lung injury
Source: Annual Congress 2003 - Mechanisms of lung injury: from bench to bedside
Year: 2003
Adaptation of differential ion mobility spectrometry (DMS) for discrimination of specific biomarkers in exhaled breath in patients with severe renal-pulmonary dysfunction
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011
Changes in exhaled breath condensate in asthma and COPD: A full analysis of mass-spectra
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010
Proteins in exhaled breath condensate: identification and pattern
Source: Annual Congress 2007 - Noninvasive evaluation of airway diseases
Year: 2007
Liquid chromatography-mass spectrometry (LC/MS) detects biomarker proteins in exhaled breath condensate (EBC) from endotracheally intubated patients collected at the exhaust port of a ventilator
Source: Eur Respir J 2006; 28: Suppl. 50, 549s
Year: 2006
Detection and variability of cytokine-levels in exhaled breath condensate (EBC) of patients with stable COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 438s
Year: 2003
Correlation between lung function and exhaled breath condensate biomarkers of inflammation in pulmonary diseases
Source: Annual Congress 2009 - Lung function in adults and children
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept